Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy

European Heart Journal

Volumn 22, Issue 15, 2001, Pages 1328-1336

  Briguori, C ^a   Betocchi, Sandro ^a   Manganelli, F ^a   Gigante, B ^b,c   Losi, M A ^a   Ciampi, Q ^a   Gottilla, R ^a   Violante, A ^a   Tocchetti, C G ^a   Volpe, M ^b,c   Chiariello, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

Cardiomyopathy; Diastole; Hypertrophy; Natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; DIASTOLE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDE, BRAIN; REGRESSION ANALYSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0034898403     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2535     Document Type: Article

References (31)

1. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
2. A new natriuretric peptide in porcine brain
3. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart
4. Brain natriuretic peptide as a novel cardiac hormone in humans
5. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure
6. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
7. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man
8. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
9. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy
10. Marker expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy
11. Expression and distribution of atrial natriuretic polypeptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy
12. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy
13. Exercise capacity is related to echocardiographic indexes of diastolic function in hypertrophic cardiomyopathy
14. Converting enzyme inhibition prevents the effects of atrial natriuretic factor on arterial baroreflexes
15. Intrarenal determinants of sodium retention in mild heart failure. Effects of angiotensinconverting enzyme inhibition
16. Diastolic abnormalities on patients with hypertrophic cardiomyopathy: Relation to magnitude of left ventricular hypertrophy
17. Noninvasive evaluation of left ventricular diastolic function in hypertrophic cardiomyopathy
18. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: Relation to left ventricular diastolic pressures
19. A practical guide to assessment of ventricular function using Doppler echocardiography
20. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy
21. Effect of mitral regurgitation on pulmonary venous flow velocities derived from transesophageal color-guided pulsed Doppler imaging
22. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure
23. Transition from asymptomatic left ventricular dysfunction to congestive heart failure
24. Atrial natriuretic peptide elevation in congestive heart failure in the human
25. Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathy: A simultaneous Doppler echocardiographic and cardiac catheterization study
26. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor
27. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation
28. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics
29. Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts
30. 2 deprivation, reduced flow, and temperature on release of ANP from rabbit hearts